Deferred Tax Assets, Valuation Allowance of CRYO CELL INTERNATIONAL INC from 30 Nov 2011 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CRYO CELL INTERNATIONAL INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Nov 2011 to 30 Nov 2025.
  • CRYO CELL INTERNATIONAL INC Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Nov 2025 was $1,502,000, a 0.13% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

CRYO CELL INTERNATIONAL INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,502,000 -$2,000 -0.13% 30 Nov 2025 10-K 27 Feb 2026 2025 FY
Q4 2024 $1,504,000 -$12,000 -0.79% 30 Nov 2024 10-K 27 Feb 2026 2025 FY
Q4 2023 $1,516,000 +$6,000 +0.4% 30 Nov 2023 10-K 28 Feb 2025 2024 FY
Q4 2022 $1,510,000 -$9,000 -0.59% 30 Nov 2022 10-K 28 Feb 2024 2023 FY
Q4 2021 $1,519,000 +$20,000 +1.3% 30 Nov 2021 10-K 28 Feb 2023 2022 FY
Q4 2020 $1,499,000 -$147,000 -8.9% 30 Nov 2020 10-K 22 Feb 2022 2021 FY
Q4 2019 $1,646,000 +$12,000 +0.73% 30 Nov 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $1,634,000 +$29,000 +1.8% 31 Aug 2019 10-Q 15 Oct 2019 2019 Q3
Q2 2019 $1,634,000 +$29,000 +1.8% 31 May 2019 10-Q 15 Jul 2019 2019 Q2
Q1 2019 $1,634,000 +$29,000 +1.8% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q1
Q4 2018 $1,634,000 -$682,000 -29% 30 Nov 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $1,605,000 -$696,000 -30% 31 Aug 2018 10-Q 15 Oct 2018 2018 Q3
Q2 2018 $1,605,000 -$696,000 -30% 31 May 2018 10-Q 16 Jul 2018 2018 Q2
Q1 2018 $1,605,000 -$696,000 -30% 28 Feb 2018 10-Q 16 Apr 2018 2018 Q1
Q4 2017 $2,316,000 +$15,000 +0.65% 30 Nov 2017 10-K 28 Feb 2019 2018 FY
Q3 2017 $2,301,000 -$329,000 -13% 31 Aug 2017 10-Q 16 Oct 2017 2017 Q3
Q2 2017 $2,301,000 -$329,000 -13% 31 May 2017 10-Q 07 Jul 2017 2017 Q2
Q1 2017 $2,301,000 -$329,000 -13% 28 Feb 2017 10-Q 13 Apr 2017 2017 Q1
Q4 2016 $2,301,000 -$329,000 -13% 30 Nov 2016 10-K 28 Feb 2018 2017 FY
Q3 2016 $2,630,000 -$929,000 -26% 31 Aug 2016 10-Q 17 Oct 2016 2016 Q3
Q2 2016 $2,630,000 -$7,557,000 -74% 31 May 2016 10-Q 11 Jul 2016 2016 Q2
Q1 2016 $2,630,000 -$7,702,000 -75% 29 Feb 2016 10-Q 14 Apr 2016 2016 Q1
Q4 2015 $2,630,000 -$7,887,000 -75% 30 Nov 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 $3,559,000 -$6,721,000 -65% 31 Aug 2015 10-Q 15 Oct 2015 2015 Q3
Q2 2015 $10,187,000 -$256,000 -2.5% 31 May 2015 10-Q 15 Jul 2015 2015 Q2
Q1 2015 $10,332,000 -$258,000 -2.4% 28 Feb 2015 10-Q 14 Apr 2015 2015 Q1
Q4 2014 $10,517,000 -$335,000 -3.1% 30 Nov 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 $10,280,000 -$443,000 -4.1% 31 Aug 2014 10-Q 15 Oct 2014 2014 Q3
Q2 2014 $10,443,000 -$442,000 -4.1% 31 May 2014 10-Q 03 Jul 2014 2014 Q2
Q1 2014 $10,590,000 -$222,000 -2.1% 28 Feb 2014 10-Q 14 Apr 2014 2014 Q1
Q4 2013 $10,852,000 -$95,000 -0.87% 30 Nov 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 $10,723,000 31 Aug 2013 10-Q 15 Oct 2013 2013 Q3
Q2 2013 $10,885,000 31 May 2013 10-Q 15 Jul 2013 2013 Q2
Q1 2013 $10,812,000 28 Feb 2013 10-Q 15 Apr 2013 2013 Q1
Q4 2012 $10,947,000 +$3,191,000 +41% 30 Nov 2012 10-K 28 Feb 2014 2013 FY
Q4 2011 $7,756,000 30 Nov 2011 10-K 28 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.